Go Pro
NASDAQ:ADGM

Adagio Medical (ADGM) Stock Price, News & Analysis

Adagio Medical logo
$0.80 +0.34 (+73.26%)
Closing price 08/4/2026 03:59 PM Eastern
Extended Trading
$0.70 -0.09 (-11.79%)
As of 04:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Adagio Medical Stock (NASDAQ:ADGM)

Advanced

Key Stats

Today's Range
$0.55
$1.13
50-Day Range
$0.37
$0.80
52-Week Range
$0.36
$2.58
Volume
474.39 million shs
Average Volume
532,514 shs
Market Capitalization
$17.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Consensus Rating
Hold

Company Overview

Adagio Medical, Inc. (NASDAQ: ADGM) is a medical device company focused on the development and commercialization of a noninvasive system for monitoring intracranial pressure (ICP). The company’s proprietary technology uses tympanic membrane displacement to provide clinicians with real-time estimates of ICP without the risks associated with invasive catheter methods. This approach is designed to improve patient safety, reduce complications, and streamline neurological monitoring in acute and critical care settings.

At the core of Adagio Medical’s pipeline is its ADGM System, which is intended for use in hospitals, emergency departments, and other clinical environments where rapid and accurate assessment of ICP is crucial. The system leverages advanced signal processing and hardware integration to capture subtle changes in ear canal pressure, translating these measurements into clinically actionable ICP values. Adagio Medical is pursuing regulatory review in key markets and has engaged in pilot studies with leading medical institutions to validate performance and ease of use.

Headquartered in Milpitas, California, Adagio Medical serves a global audience of neurosurgeons, neurologists, and critical care specialists. The company has established collaborations with academic medical centers and research organizations to further refine its technology and expand potential applications, including traumatic brain injury, hydrocephalus management, stroke care, and pediatric neurology. These partnerships help support ongoing clinical trials and product development initiatives aimed at broadening the system’s utility across various patient populations.

Led by CEO Keld Refsgaard, PhD, Adagio Medical draws upon a team of engineers, clinicians, and regulatory experts to drive innovation and navigate complex approval pathways. The company’s management emphasizes a commitment to scientific rigor, patient-centric design, and strategic collaboration as it works toward commercial launch and market adoption of its noninvasive ICP monitoring solution.

AI Generated. May Contain Errors.

Adagio Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

ADGM MarketRank™: 

Adagio Medical scored higher than 33% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Adagio Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Adagio Medical has a consensus price target of $3.50, representing about 339.1% upside from its current price of $0.80.

  • Amount of Analyst Coverage

    Adagio Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Adagio Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Adagio Medical are expected to decrease in the coming year, from ($1.58) to ($2.33) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Adagio Medical is -0.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Adagio Medical is -0.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Adagio Medical has a P/B Ratio of 1.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Adagio Medical's valuation and earnings.
  • Percentage of Shares Shorted

    0.31% of the float of Adagio Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Adagio Medical has a short interest ratio ("days to cover") of 0.96, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Adagio Medical has recently increased by 3.74%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Adagio Medical does not currently pay a dividend.

  • Dividend Growth

    Adagio Medical does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Adagio Medical this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for ADGM on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Adagio Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    7.81% of the stock of Adagio Medical is held by insiders.

  • Percentage Held by Institutions

    48.08% of the stock of Adagio Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Adagio Medical's insider trading history.
Receive ADGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adagio Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ADGM Stock News Headlines

Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
Adagio Medical Holdings Stock Price History
Adagio Medical Holdings Inc ADGM
See More Headlines

ADGM Stock Analysis - Frequently Asked Questions

Adagio Medical's stock was trading at $1.04 at the beginning of the year. Since then, ADGM stock has decreased by 23.4% and is now trading at $0.7970.

Adagio Medical Holdings, Inc. (NASDAQ:ADGM) announced its quarterly earnings results on Tuesday, May, 12th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.29) by $0.02.

Shares of ADGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Adagio Medical investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), Baidu (BIDU).

Company Calendar

Last Earnings
5/12/2026
Today
8/04/2026
Next Earnings (Estimated)
8/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:ADGM
Previous Symbol
NASDAQ:ADGM
CIK
2006986
Fax
N/A
Employees
87
Year Founded
2023

Price Target and Rating

High Price Target
$4.00
Low Price Target
$3.00
Potential Upside/Downside
+339.1%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.53)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$25.08 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-382.50%
Return on Assets
-64.98%

Debt

Debt-to-Equity Ratio
4.00
Current Ratio
1.85
Quick Ratio
1.66

Sales & Book Value

Annual Sales
$600 thousand
Price / Sales
29.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.59 per share
Price / Book
1.35

Miscellaneous

Outstanding Shares
22,210,000
Free Float
20,475,000
Market Cap
$17.70 million
Optionable
N/A
Beta
-0.15
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:ADGM) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners